Skeletal Muscle Oxygenation in Critically Ill

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University Medical Centre Ljubljana.
Recruitment status was  Recruiting
Information provided by:
University Medical Centre Ljubljana Identifier:
First received: October 4, 2006
Last updated: June 4, 2008
Last verified: June 2008
It is possible to measure skeletal muscle tissue oxygenation (StO2) using near infrared spectroscopy(NIRS). It is performed non invasively. We want to compare usually used invasive methods for assessing adequacy of flow to StO2 in critically ill. Aim is to faster and non invasively estimate adequacy of flow to make therapeutic algorithms efficient.

Condition Intervention
Heart Failure
Septic Shock
Cardiogenic Shock
Device: NiRS measurment of tissue oxygenation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Skeletal Muscle Oxygenation in Critically Ill

Resource links provided by NLM:

Further study details as provided by University Medical Centre Ljubljana:

Estimated Enrollment: 200
Study Start Date: April 2004
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
sepsis, septic shock ptients
Device: NiRS measurment of tissue oxygenation
NiRS measurment of tissue oxygenation
cardiogenic shock patients
Device: NiRS measurment of tissue oxygenation
NiRS measurment of tissue oxygenation

  Show Detailed Description


Ages Eligible for Study:   18 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Intensive care patients

Inclusion Criteria:

  • all typs of shock (cardiogenic, septic, hypovolemic, obstractive)

Exclusion Criteria:

  • patients/relatives refuse to participate in study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00384644

Contact: Matej Podbregar, MD PhD +386 40 215960
Contact: Hugon Mozina, MD +386 41 779078

Clinical Center Ljubljana Recruiting
Ljubljana, Slovenia, 1000
Contact: Matej Podbregar, MD PhD    +386 40 215960   
Sub-Investigator: Hugon Mozina, MD         
Sponsors and Collaborators
University Medical Centre Ljubljana
Principal Investigator: Matej Podbregar, MD PhD Medical Faculty, University of Ljubljana
  More Information

Additional publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Matej Podbregar, UMC Ljubljana Identifier: NCT00384644     History of Changes
Other Study ID Numbers: NIRS-1
Study First Received: October 4, 2006
Last Updated: June 4, 2008
Health Authority: Slovenia: Ministry of Health

Keywords provided by University Medical Centre Ljubljana:
heart failure
septic shock
cardiogenic shock

Additional relevant MeSH terms:
Critical Illness
Heart Failure
Shock, Cardiogenic
Shock, Septic
Cardiovascular Diseases
Disease Attributes
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Pathologic Processes
Systemic Inflammatory Response Syndrome
Vascular Diseases processed this record on November 27, 2015